Search
for
Sort by
Research 30 of 1000+
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Novel therapies for alopecia areata: The era of rational drug development
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- Dupilumab: Friend or Foe to Alopecia Areata?
- Alopecia Areata: A Complex Cytokine Driven Disease
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- New and Emerging Therapies for Alopecia Areata
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation
- Norepinephrine Regulates Keratinocyte Proliferation to Promote the Growth of Hair Follicles
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Systemic Therapies for Scarring and Non-scarring Alopecia